Clinical Trials
Discover the future of medicine today. Yale Medicine currently offers 692 active clinical trials across our hospitals and care centers, providing our patients with early access to many of the world’s most advanced therapies. Yale Center for Clinical Investigation (YCCI) supports, coordinates, and oversees clinical trials, ensuring the safety of trial volunteers.
For more information about cancer-related trials, call us at 203-785-5702. For all other trials, call 877-978-8343.
9 Results
- Skin/Dermatology
A Phase 3 Multicenter, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lutikizumab in Adult and Adolescent Subjects with Moderate to Severe Hidradenitis Suppurativa
- Skin/Dermatology
A Phase 3, Randomized, Multicenter, Double-Blind Trial to Evaluate the Efficacy, Safety, and Tolerability of Zasocitinib (TAK-279) Compared to Deucravacitinib in Participants With Moderate-to-Severe Plaque Psoriasis
- Skin/Dermatology
A Two-part, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of APG777 in Patients with Moderate-to-severe Atopic Dermatitis
- Skin/Dermatology
Atopic Dermatitis: A Study of Upadacitinib in Adult Subjects with Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (SWITCH-UP)
- Skin/Dermatology
Does Ichthyosis Affect Growth Among Children?
- Skin/Dermatology
- Genetics
- Gender:All Genders
- Age:25 years and younger
Genome Research in African American Scleroderma Patients (GRASP Study)
- Skin/Dermatology
- Immune System
- Gender:All Genders
- Age:18 years and older
JAK1 inhibition in sarcoidosis: an opportunity for pathogenesis directed therapy
- Skin/Dermatology
- Gender:All Genders
- Age:18 years and older
RESET-Systemic Lupus Erythematosus (SLE)
- Skin/Dermatology
- Immune System
The Scleroderma Patient-centered Intervention Network (SPIN)
- Skin/Dermatology
- Orthopaedics, Muscle & Bone
- Gender:All Genders
- Age:18 years and older